LYVE1 and Miyoshi myopathy: Since metastatic spread correlated with LD, even in thin melanomas (Figure 2), these results indicate that patients whose biopsy has a high LYVE-1 count could be included in a more intensive follow-up schedule, or considered for adjuvant treatment, even if the MM is thin.